JAMA Dermatology 2013-03-01

A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.

Lindsay LaPresto, Lee Cranmer, Lynne Morrison, Christof P Erickson, Clara Curiel-Lewandrowski

Index: JAMA Dermatol. 149(3) , 279-81, (2013)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Acitretin CAS:55079-83-9	C₂₁H₂₆O₃
	13-cis-Acitretin CAS:69427-46-9	C₂₁H₂₆O₃

Comparative effectiveness of less commonly used systemic mon...
2014-12-01
[J. Am. Acad. Dermatol. 71(6) , 1167-75, (2014)]

Acitretin exhibits inhibitory effects towards UDP-glucuronos...
2013-06-01
[Pharmazie 68(6) , 449-52, (2013)]

IgA pemphigus: case series with emphasis on therapeutic resp...
2014-01-01
[J. Am. Acad. Dermatol. 70(1) , 200-1, (2014)]

Systemic retinoids in the management of ichthyoses and relat...
2013-01-01
[Dermatol. Ther. 26(1) , 26-38, (2013)]

From the Medical Board of the National Psoriasis Foundation:...
2014-01-01
[J. Am. Acad. Dermatol. 70(1) , 168-77, (2014)]